» Articles » PMID: 22966168

VEGF-A Recruits a Proangiogenic MMP-9-delivering Neutrophil Subset That Induces Angiogenesis in Transplanted Hypoxic Tissue

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2012 Sep 12
PMID 22966168
Citations 175
Authors
Affiliations
Soon will be listed here.
Abstract

Recruitment and retention of leukocytes at a site of blood vessel growth are crucial for proper angiogenesis and subsequent tissue perfusion. Although critical for many aspects of regenerative medicine, the mechanisms of leukocyte recruitment to and actions at sites of angiogenesis are not fully understood. In this study, we investigated the signals attracting leukocytes to avascular transplanted pancreatic islets and leukocyte actions at the engraftment site. Expression of the angiogenic stimulus VEGF-A by mouse pancreatic islets was elevated shortly after syngeneic transplantation to muscle. High levels of leukocytes, predominantly CD11b(+)/Gr-1(+)/CXCR4(hi) neutrophils, were observed at the site of engraftment, whereas VEGF-A-deficient islets recruited only half of the amount of leukocytes when transplanted. Acute VEGF-A exposure of muscle increased leukocyte extravasation but not the levels of SDF-1α. VEGF-A-recruited neutrophils expressed 10 times higher amounts of MMP-9 than neutrophils recruited to an inflammatory stimulus. Revascularization of islets transplanted to MMP-9-deficient mice was impaired because blood vessels initially failed to penetrate grafts, and after 2 weeks vascularity was still disturbed. This study demonstrates that VEGF-A recruits a proangiogenic circulating subset of CD11b(+)/Gr-1(+) neutrophils that are CXCR4(hi) and deliver large amounts of the effector protein MMP-9, required for islet revascularization and functional integration after transplantation.

Citing Articles

The post-orchiectomy systemic inflammatory index is associated with tumor characteristics in clinical stage I germ cell tumors.

Lesko P, Mego M Front Oncol. 2025; 15:1490264.

PMID: 40066096 PMC: 11891062. DOI: 10.3389/fonc.2025.1490264.


The prognostic value of pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients with esophageal cancer undergoing immunotherapy: a systematic review and meta-analysis.

Deng M, Qing Y, Qiu D, Sheng Y, Zhou J, Sun L Front Oncol. 2025; 15:1536920.

PMID: 40027124 PMC: 11868166. DOI: 10.3389/fonc.2025.1536920.


Modic changes: From potential molecular mechanisms to future research directions (Review).

Zhu W, Yang Z, Zhou S, Zhang J, Xu Z, Xiong W Mol Med Rep. 2025; 31(4).

PMID: 39918002 PMC: 11836598. DOI: 10.3892/mmr.2025.13455.


Spatially mapping the tumour immune microenvironments of non-small cell lung cancer.

Desharnais L, Sorin M, Rezanejad M, Liu B, Karimi E, Atallah A Nat Commun. 2025; 16(1):1345.

PMID: 39905080 PMC: 11794701. DOI: 10.1038/s41467-025-56546-x.


Neutrophil heterogeneity and plasticity: unveiling the multifaceted roles in health and disease.

He W, Yan L, Hu D, Hao J, Liou Y, Luo G MedComm (2020). 2025; 6(2):e70063.

PMID: 39845896 PMC: 11751288. DOI: 10.1002/mco2.70063.


References
1.
Bohman S, Andersson A, King A . No differences in efficacy between noncultured and cultured islets in reducing hyperglycemia in a nonvascularized islet graft model. Diabetes Technol Ther. 2006; 8(5):536-45. DOI: 10.1089/dia.2006.8.536. View

2.
Dubois B, Masure S, Hurtenbach U, Paemen L, Heremans H, van den Oord J . Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions. J Clin Invest. 1999; 104(11):1507-15. PMC: 409857. DOI: 10.1172/JCI6886. View

3.
Van den Steen P, Dubois B, Nelissen I, Rudd P, Dwek R, Opdenakker G . Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol. 2003; 37(6):375-536. DOI: 10.1080/10409230290771546. View

4.
Yi L, Rossi F . Purification of progenitors from skeletal muscle. J Vis Exp. 2011; (49). PMC: 3197294. DOI: 10.3791/2476. View

5.
Ardi V, Kupriyanova T, Deryugina E, Quigley J . Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis. Proc Natl Acad Sci U S A. 2007; 104(51):20262-7. PMC: 2154419. DOI: 10.1073/pnas.0706438104. View